uniQure N.V.
NASDAQ:QURE · NASDAQ Global Select
-$1.13 today
Vol 4.35M · Avg 1.75M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+231.83%
Period High
$70.59
Period Low
$9.03
Latest
$46.29
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
$3.83B
Structure Therapeutics Inc.
NASDAQ:GPCR
$2.65B
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.50B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.19B
Ocular Therapeutix, Inc.
NASDAQ:OCUL
$2.10B
Nuvation Bio Inc.
NYSE:NUVB
$1.89B
Galapagos N.V.
GLPG
$1.84B
Mesoblast Limited
NASDAQ:MESO
$1.84B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.67B
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$1.50B
What is the latest QURE filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does QURE have?
Intrinsic Alpha currently shows 20 recent filings for QURE.
Explore More
Continue the stock analysis
Jump to another research area for this company.